Abstract
Context: Biomarkers that predict musculoskeletal response to anabolic therapies should expedite drug development. During collagen synthesis in soft lean tissue, N-terminal propeptide of type III procollagen (P3NP) is released into circulation. We investigated P3NP as a biomarker of lean body mass (LBM) and muscle strength gains in response to testosterone and GH.
Design: Community-dwelling older men received GnRH agonist plus 5 or 10 g testosterone gel plus 0, 3, or 5 μg recombinant human GH daily. P3NP levels were measured at baseline and wk 4, 8, 12, and 16. LBM and appendicular skeletal muscle mass (ASM) were measured by dual-energy x-ray absorptiometry.
Results: One hundred twelve men completed treatment; 106 underwent serum P3NP measurements. P3NP levels were higher at wk 4 than baseline (6.61 ± 2.14 vs. 4.51 ± 1.05, P < 0.0001) and reached plateau by wk 4 in men receiving testosterone alone. However, wk 8 P3NP levels were higher than wk 4 levels in men receiving testosterone plus recombinant human GH. Increases in P3NP from baseline to wk 4 and 16 were significantly associated with gains in LBM (r = 0.26, P = 0.007; r = 0.53, P < 0.001) and ASM (r = 0.17, P = 0.07; r = 0.40, P < 0.0001). Importantly, for participants receiving only testosterone, P3NP increases at wk 4 and 16 were related to muscle strength gains (r = 0.20, P = 0.056 and r = 0.36, P = 0.04). In stepwise regression, change in P3NP explained 28 and 30% of the change in ASM and LBM, respectively, whereas change in testosterone but not IGF-I and age provided only small improvements in the models.
Conclusion: Early changes in serum P3NP levels are associated with subsequent changes in LBM and ASM during testosterone and GH administration. Serum P3NP may be a useful early predictive biomarker of anabolic response to GH and testosterone.
Keywords
biomarkers, anabolic therapy, type III procollagen (P3NP), lean body mass (LBM), quantitative study
Subject Categories
Biochemical markers, Musculoskeletal system - Metabolism, Recombinant human somatotropin
Disciplines
Endocrinology, Diabetes, and Metabolism
Publisher
The Endocrine Society
Publication Date
11-2009
Rights Information
Copyright © 2009
Rights Holder
The Endocrine Society
Permanent URL
Recommended Citation
Bhasin, Shalender (1953-); He, E. Jiaxiu; Kawabuko, Miwa; Schroeder, E. Todd; Yarasheski, Kevin; Opitek, Gregory J.; Reicin, Alise; Chen, Fabian; Lam, Raymond; Tsou, Jeffrey A.; Castaneda-Sceppa, Carmen; Binder, Ellen F.; Azen, Stanley P.; and Sattler, Fred R., "N-terminal propeptide of Type III procollagen as a biomarker of anabolic response to recombinant human GH and testosterone" (2009). Bouvé Faculty Publications. Paper 19. http://hdl.handle.net/2047/d20000958
Click button above to open, or right-click to save.




Notes
Originally published in the Journal of Clinical Endocrinology & Metabolism v.94 no.11 (November 1, 2009), pp.4224-4233. DOI: 10.1210/jc.2009-1434